- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE Gets FDA Approval for Mobile X-Ray Systems
GE Healthcare has received FDA clearance of its Optima XR220amx, Optima XR200amx and Brivo XR285amx, a new platform of mobile x-ray systems.
GE Healthcare has received FDA clearance of its Optima XR220amx, Optima XR200amx and Brivo XR285amx, a new platform of mobile x-ray systems.
The product line responds to aging populations, rising obesity rates, and an increasing demand for patient-centric medical care by creating a “radiology room on wheels.”
The machines provide fast, low-dose images for diagnoses in challenging clinical settings.
The digital Optima XR220amx, digital-ready Optima XR200amx and Brivo XR285amx, are more compact and powerful than earlier models, featuring intuitive touch screens, immediate start-up capability, more storage and the high image quality required today.
The Optima XR220amx also immediately integrates with GE’s FlashPad digital wireless detector.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
